Turk Ilac Ve Serum Sanayi Anonim Sirketi Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
For the six months, sales was TRY 443.49 million compared to TRY 303.75 million a year ago. Net income was TRY 31.91 million compared to TRY 56.07 million a year ago. Basic earnings per share from continuing operations was TRY 0.197 compared to TRY 0.3467 a year ago.